Skip to contentApplication 211581
- Type
- ANDA
- Sponsor
- AGNITIO
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | TRIAMTERENE | TRIAMTERENE | CAPSULE;ORAL | 50MG | No | No |
| 002 | TRIAMTERENE | TRIAMTERENE | CAPSULE;ORAL | 100MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 52817-364 | Triamterene | Triamterene Capsules | TRUPHARMA LLC | ANDA | Current |
| 52817-364 | Triamterene | Triamterene Capsules | TRUPHARMA LLC | ANDA | Current |
| 52817-364 | Triamterene | Triamterene Capsules | TRUPHARMA LLC | ANDA | Current |
| 52817-364 | Triamterene | Triamterene Capsules | TRUPHARMA LLC | ANDA | Current |
| 52817-365 | Triamterene | Triamterene Capsules | TRUPHARMA LLC | ANDA | Current |
| 52817-365 | Triamterene | Triamterene Capsules | TRUPHARMA LLC | ANDA | Current |
| 52817-365 | Triamterene | Triamterene Capsules | TRUPHARMA LLC | ANDA | Current |
| 52817-365 | Triamterene | Triamterene Capsules | TRUPHARMA LLC | ANDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 60149 | ORIG | 2019-09-30 |